NCT05437276View on ClinicalTrials.gov

A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS)

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)
Interventions
DEVICE

PoNS®

The PoNS device used in conjunction with rehabilitative physical therapy

Trial Locations (5)

10016

NYU Langone Health, NYU Grossman School of Medicine, New York

30309

Shepherd Center, Atlanta

97239

Oregon Health and Science university (OHSU), Portland

02129

MGH Institute of Health Professions, Boston

02035

Neurology Center of New England, P.C., Foxborough

Sponsors

Lead Sponsor

Helius Medical Inc
All Listed Sponsors
lead

Helius Medical Inc

INDUSTRY

NCT05437276 - A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS) | Biotech Hunter | Biotech Hunter